Caris Life Sciences CAI
NASDAQ CAI
$25.09 -0.23 (-0.91%)
As of: Sep 4, 2026 · 3:59 PM EDT

Caris Life Sciences (CAI) Amortizatization of Intangibles (2024 - 2026)

Caris Life Sciences (CAI) posted quarterly Amortizatization of Intangibles of $2.6 million for Q1 2026, up 34.91% year-over-year from $1.9 million in Q1 2025, and up 333.72% quarter-over-quarter from $605000.0 in Q4 2025.

Analysis

Caris Life Sciences (CAI) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends

Caris Life Sciences' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $2.6 million for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles rose 34.91% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $13.4 million (up 81.5% YoY), while the FY2025 annual figure was $12.8 million, up 81.0% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $2.6 million, up from $605000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $7.8 million in Q2 2025, with the low at $605000.0 in Q4 2025.
  • The 3-year median for Amortizatization of Intangibles is $1.9 million (2024), against an average of $2.6 million.
  • Peak annual rise in Amortizatization of Intangibles reached 348.01% in 2025, while the deepest fall reached 68.26% in 2025.
  • Caris Life Sciences' Amortizatization of Intangibles stood at $1.9 million in 2024, then tumbled by 68.26% to $605000.0 in 2025, then jumped by 333.72% to $2.6 million in 2026.
  • Business Quant data shows CAI's Amortizatization of Intangibles at $2.6 million in Q1 2026, $605000.0 in Q4 2025, and $2.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Caris Life Sciences 7.08 Bn 6.28 Bn 182.38 Mn 298,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 298,000.00
Mar 31, 2026 2.62 Mn
Dec 31, 2025 605,000.00
Sep 30, 2025 2.46 Mn
Jun 30, 2025 7.76 Mn
Mar 31, 2025 1.95 Mn
Dec 31, 2024 1.91 Mn
Sep 30, 2024 1.83 Mn
Jun 30, 2024 1.73 Mn